Forbes

Engineered exosomes that naturally go to brain and kidney cells can deliver gene‑silencing drugs far beyond the liver.

Forus reached $1 billion valuation by dealing with the unglamorous admin work of processing scrips so patients can get the drugs they need.

Dr. Omer Awan details lessons from COVID-19 that should be driving the U.S. response in order to contain the Andes hantavirus outbreak.

Jay Bhattacharya dismissed the test-negative design as 'crap.' The biostatistics literature tells a different story.

A nanobody that stabilizes mutant CFTR from inside the cell, especially when combined with existing drugs, restores near-normal function in cystic fibrosis cells.

Peptides have entered the menopause conversation, but growing interest in optimization and hormone health is also raising questions about safety & long-term evidence.

There’s certainly no shortage of things to do with your mother present on Mother’s Day. But what do you do on this day when your mom's gone. Here are 10 possibilities.

Health insurance companies including UnitedHealthcare, CVS Health’s Aetna and Blue Cross and Blue Shield plans are seeing lower costs. But there’s trouble ahead.

USAID is gone. With 14 million deaths projected by 2030, can Trump's "Trade Over Aid" initiative replace decades of global health infrastructure?

Should Medicare change the default option for new beneficiaries to Medicare Advantage or an ACO, this could backfire as costs could rise and access restrictions increase.

Kennedy touts MAHA. This Mother's Day, note what his misinformation and policies really do to moms: reduce access to care, increase deaths and guilt from responsibilities.

Will Hantavirus cause the next pandemic? A public health expert explains why it is unlikely to result in a global pandemic, and discusses the U.S. response thus far

Synthetic microbiomes to treat disease. Sea levels may rise faster than we thought. AI for scientific researchers. All that and more in this week’s edition of The Prototype.

Leading spine societies have issued a powerful new consensus statement urging insurers to reimburse for interbody devices in anterior cervical spine surgery.

In Congress, hearings on healthcare tend to function as venues for adversarial political messaging and electoral gain rather than legislative consensus-building.